This model can be used to predict the pre-test probability (prior probability)
that a person has a BRCA1 or BRCA2 mutation. Other models exist,
which may provide different estimates.
This model does not predict breast cancer risk. It focuses only on the chance that an individual has
inherited a mutation in BRCA1 or BRCA2.
Decisions regarding genetic testing typically include consideration of personal
and family history of cancer, national and/or professional group recommendations
(e.g., NCCN, USPSTF), insurance criteria and/or patient preferences, in addition
to pre-test probability estimates such as provided by this model.